Home New Launches

New Launches

Diabetes India launches the ‘1000 Days Initiative’ leading up to January 11, 2022 to...

The Initiative brings together endocrinologists and GPs to improve diabetes diagnosis, lower HbA1c levels, prevent diabetes-linked complications and bring diabetes under control in India New Delhi, April 17, 2019: January 11, 2022 will mark 100 years of insulin use, when...

Dr. Reddy’s Laboratories launches Tadalafil Tablets USP in the U.S. Market

Hyderabad, March 28, 2019: Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version...